Chia F L, Leong K P. Severe cutaneous adverse reactions to drugs [J]. Curr Opin Allergy Clin Immunol, 2007, 7 (4): 304-309.
[1]
Chia F L, Leong K P. Severe cutaneous adverse reactions to drugs [J]. Curr Opin Allergy Clin Immunol, 2007, 7 (4): 304-309.
[2]
Odom R B. 安德鲁斯皮肤病学[M]. 9版. 北京: 科学出版社, 2001: 132-135.
[2]
Odom R B. 安德鲁斯皮肤病学[M]. 9版. 北京: 科学出版社, 2001: 132-135.
[3]
Braun-Falco O, Plewig G, Burgdorf W H C, et al. Braun-Falco's Dermatology[M]. 3rd Edition. Berlin: Springer-Verlag Berlin and Heidelberg GmbH & Co. K. 2008: 473-483.
[3]
Braun-Falco O, Plewig G, Burgdorf W H C, et al. Braun-Falco's Dermatology[M]. 3rd Edition. Berlin: Springer-Verlag Berlin and Heidelberg GmbH & Co. K. 2008: 473-483.
[4]
Patel P P, Gandhi A M, Desai C K, et al. An analysis of drug induced Stevens-Johnson syndrome [J]. Indian J Med Res,2012, 136(6): 1051-1053.
[4]
Patel P P, Gandhi A M, Desai C K, et al. An analysis of drug induced Stevens-Johnson syndrome [J]. Indian J Med Res,2012, 136(6): 1051-1053.
[5]
Angelopoulou M A, Poziopoulos C, Boussiotis V A,et al. Fludarabine monophosphate in refractory B-chronic lymphocytic leukemia: maintenance may be significant to sustain response[J]. Leuk Lymphoma, 1996,21(3-4):321-324.
[5]
Angelopoulou M A, Poziopoulos C, Boussiotis V A,et al. Fludarabine monophosphate in refractory B-chronic lymphocytic leukemia: maintenance may be significant to sustain response[J]. Leuk Lymphoma, 1996,21(3-4):321-324.
[6]
Klasa R J, Meyer R M, Shustik C, et al. Randomized phase Ⅲ study of fludarabine phosphate versus cyclophosphamide, vincristine, and prednisone in patients with recurrent low-grade non-Hodgkin’s lymphoma previously treated with an alkylating agent or alkylator-containing regimen[J]. J Clin Oncol,2002,20(24):4649-4654.
[6]
Klasa R J, Meyer R M, Shustik C, et al. Randomized phase Ⅲ study of fludarabine phosphate versus cyclophosphamide, vincristine, and prednisone in patients with recurrent low-grade non-Hodgkin’s lymphoma previously treated with an alkylating agent or alkylator-containing regimen[J]. J Clin Oncol,2002,20(24):4649-4654.
2014, Vol. 25 
